What is the best approach to patients with clopidogrel resistance undergoing vascular interventions?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18787280
Cited by: 0

Abstract

The best approach for patients with clopidogrel resistance undergoing vascular interventions involves genetic testing to guide the selection of alternative antiplatelet therapy, such as ticagrelor or prasugrel, to potentially improve outcomes.

Fields of Study & Subjects

Antiplatelet Therapy and Cardiovascular Diseases Coronary Interventions and Diagnostics Blood Coagulation and Thrombosis Mechanisms

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
26 February 2026
Language
EN